Exploring Immunotherapy Biomarkers And Patient Selection
Exploring Immunotherapy Biomarkers And Patient Selection reveals several interesting facts.
- Shilpa Gupta, MD, assistant professor of medicine, Hematology/Oncology and Transplantation Division, University of Minnesota, ...
- Sergio Quezada underlines that understanding mechanisms that underpin the immune regulation is key for targeting and ...
- If you're a
- With the aid of
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
In-Depth Information on Immunotherapy Biomarkers And Patient Selection
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for ... Tanja D. de Druijl Our ever increasing knowledge of the mechanisms that underlie Prostate Cancer has yielded novel and ... In this video, Akiva Diamond, MD, Baylor College of Medicine, Houston, TX, briefly comments on the potential of improving Hanny Al-Samkari, MD, Massachusetts General Hospital, Boston, MA, comments on the challenges of identifying
Mark Yarchoan, MD, Johns Hopkins University, Baltimore, MD, provides an overview of emerging
Stay tuned for more updates related to Immunotherapy Biomarkers And Patient Selection.